Published in Curr Neuropharmacol on September 01, 2012
Animal use in pharmacology education and research: the changing scenario. Indian J Pharmacol (2014) 1.45
Zebrafish as an emerging model for studying complex brain disorders. Trends Pharmacol Sci (2014) 1.26
Perspectives on zebrafish models of hallucinogenic drugs and related psychotropic compounds. ACS Chem Neurosci (2013) 0.83
Early-life glucocorticoids programme behaviour and metabolism in adulthood in zebrafish. J Endocrinol (2016) 0.77
Fingerprinting of psychoactive drugs in zebrafish anxiety-like behaviors. PLoS One (2014) 0.77
Long-term habituation of the C-start escape response in zebrafish larvae. Neurobiol Learn Mem (2016) 0.75
Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol (1991) 14.25
The human connectome: A structural description of the human brain. PLoS Comput Biol (2005) 14.12
Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature (2011) 8.25
The cholinergic hypothesis of geriatric memory dysfunction. Science (1982) 6.84
Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) (2001) 5.67
Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group. Arch Intern Med (1998) 4.43
The human connectome: a complex network. Ann N Y Acad Sci (2011) 4.07
Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl) (2005) 3.92
Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature (1996) 3.79
Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome. Nat Neurosci (2007) 3.74
Zebrafish comparative genomics and the origins of vertebrate chromosomes. Genome Res (2000) 3.50
Brain graphs: graphical models of the human brain connectome. Annu Rev Clin Psychol (2011) 3.36
Cognitive impairment in schizophrenia is the core of the disorder. Crit Rev Neurobiol (2000) 3.17
Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans. Proc Natl Acad Sci U S A (2007) 3.02
Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol Psychiatry (1995) 2.72
Catching up on schizophrenia: natural history and neurobiology. Neuron (2000) 2.63
Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. Am J Psychiatry (2000) 2.61
Modeling madness in mice: one piece at a time. Neuron (2006) 2.60
Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish. Behav Brain Res (2009) 2.56
3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensor-based morphometry. Neuroimage (2008) 2.40
A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients. Neurology (2001) 2.38
A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neuronal architecture and cognition. Proc Natl Acad Sci U S A (2008) 2.37
Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease. J Neurosci (2005) 2.34
3D structural imaging of the brain with photons and electrons. Curr Opin Neurobiol (2009) 2.28
Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review. Pharmacol Res (2010) 2.26
Sensorimotor gating in larval zebrafish. J Neurosci (2007) 2.25
Ethanol effects on the developing zebrafish: neurobehavior and skeletal morphogenesis. Neurotoxicol Teratol (2004) 2.24
A genetically encoded reporter of synaptic activity in vivo. Nat Methods (2009) 2.20
Imaging neuronal activity during zebrafish behavior with a genetically encoded calcium indicator. J Neurophysiol (2003) 2.16
Optogenetic tools for analyzing the neural circuits of behavior. Trends Cogn Sci (2011) 2.15
alx, a zebrafish homolog of Chx10, marks ipsilateral descending excitatory interneurons that participate in the regulation of spinal locomotor circuits. J Neurosci (2006) 2.09
Specific developmental disruption of disrupted-in-schizophrenia-1 function results in schizophrenia-related phenotypes in mice. Proc Natl Acad Sci U S A (2007) 2.04
Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging. Radiology (2003) 2.00
Drosophila Brainbow: a recombinase-based fluorescence labeling technique to subdivide neural expression patterns. Nat Methods (2011) 1.98
Donepezil therapy in clinical practice: a randomized crossover study. Arch Neurol (2000) 1.93
To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology (2000) 1.89
Efficacy of atypical v. typical antipsychotics in the treatment of early psychosis: meta-analysis. Br J Psychiatry (2010) 1.76
Analyzing habituation responses to novelty in zebrafish (Danio rerio). Behav Brain Res (2009) 1.69
Synaptic potentials mediated via alpha-bungarotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampal interneurons. J Neurosci (1998) 1.66
A history of optogenetics: the development of tools for controlling brain circuits with light. F1000 Biol Rep (2011) 1.59
Optical probing of neuronal circuit dynamics: genetically encoded versus classical fluorescent sensors. Trends Neurosci (2006) 1.56
alpha-bungarotoxin- and methyllycaconitine-sensitive nicotinic receptors mediate fast synaptic transmission in interneurons of rat hippocampal slices. Brain Res (1998) 1.55
Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull (1998) 1.53
Home base behavior of rats (Rattus norvegicus) exploring a novel environment. Behav Brain Res (1989) 1.51
Orienting to social stimuli differentiates social cognitive impairment in autism and schizophrenia. Neuropsychologia (2007) 1.51
A novel approach to the human connectome: ultra-high resolution mapping of fiber tracts in the brain. Neuroimage (2010) 1.50
High-throughput behavioral screens: the first step towards finding genes involved in vertebrate brain function using zebrafish. Molecules (2010) 1.49
Sight of conspecifics as reward in associative learning in zebrafish (Danio rerio). Behav Brain Res (2007) 1.48
What's wrong with my mouse model? Advances and strategies in animal modeling of anxiety and depression. Behav Brain Res (2007) 1.41
A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry. J Neurol Neurosurg Psychiatry (2006) 1.39
The role of serotonin receptors in the action of atypical antipsychotic drugs. Curr Opin Pharmacol (2011) 1.38
New translational assays for preclinical modelling of cognition in schizophrenia: the touchscreen testing method for mice and rats. Neuropharmacology (2011) 1.37
Visual perceptual and working memory impairments in schizophrenia. Arch Gen Psychiatry (2002) 1.36
A cog in cognition: how the alpha 7 nicotinic acetylcholine receptor is geared towards improving cognitive deficits. Pharmacol Ther (2009) 1.31
Circuit neuroscience in zebrafish. Curr Biol (2010) 1.30
Modeling anxiety using adult zebrafish: a conceptual review. Neuropharmacology (2011) 1.28
Non-associative learning in larval zebrafish. Neuropsychopharmacology (2007) 1.27
Nicotinic involvement in memory function in zebrafish. Neurotoxicol Teratol (2004) 1.26
Topological reorganization of odor representations in the olfactory bulb. PLoS Biol (2007) 1.26
A simple spatial alternation task for assessing memory function in zebrafish. Behav Processes (2002) 1.26
Grey matter atrophy in cognitively impaired Parkinson's disease. J Neurol Neurosurg Psychiatry (2011) 1.25
Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer's disease. CNS Drugs (2001) 1.24
Differences in spatio-temporal behavior of zebrafish in the open tank paradigm after a short-period confinement into dark and bright environments. PLoS One (2011) 1.23
Genetic factors in Alzheimer's disease. N Engl J Med (2005) 1.23
Timing of nicotine effects on learning in zebrafish. Psychopharmacology (Berl) (2005) 1.21
Prepulse inhibition and genetic mouse models of schizophrenia. Behav Brain Res (2009) 1.20
Use of zebrafish as a model to understand mechanisms of addiction and complex neurobehavioral phenotypes. Neurobiol Dis (2010) 1.20
The role of alpha7 and alpha4beta2 nicotinic receptors in the nicotine-induced anxiolytic effect in zebrafish. Physiol Behav (2008) 1.20
Disrupted-in-schizophrenia 1 and neuregulin 1 are required for the specification of oligodendrocytes and neurones in the zebrafish brain. Hum Mol Genet (2008) 1.19
Stopping behavior: constraints on exploration in rats (Rattus norvegicus). Behav Brain Res (1993) 1.19
Impaired performance of alpha7 nicotinic receptor knockout mice in the five-choice serial reaction time task. Psychopharmacology (Berl) (2006) 1.19
Effects of dizocilpine (MK-801) on circling behavior, swimming activity, and place preference in zebrafish (Danio rerio). Neurotoxicol Teratol (2004) 1.16
The ADHD-susceptibility gene lphn3.1 modulates dopaminergic neuron formation and locomotor activity during zebrafish development. Mol Psychiatry (2012) 1.16
Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes. Brain (1997) 1.15
Multicolor Brainbow imaging in zebrafish. Cold Spring Harb Protoc (2011) 1.14
Effects of smoking on acoustic startle and prepulse inhibition in humans. Psychopharmacology (Berl) (2001) 1.13
Cognitive aging in zebrafish. PLoS One (2006) 1.12
Haplotype transmission disequilibrium and evidence for linkage of the CHRNA7 gene region to schizophrenia in Southern African Bantu families. Am J Med Genet (2000) 1.11
Modeling withdrawal syndrome in zebrafish. Behav Brain Res (2009) 1.10
Effects of antipsychotics on prepulse inhibition of the startle response in drug-naïve schizophrenic patients. Biol Psychiatry (2002) 1.08
Cholinesterase inhibitors for Alzheimer's disease. Drugs (2001) 1.08
Prepulse inhibition of the startle response in men with schizophrenia: effects of age of onset of illness, symptoms, and medication. Arch Gen Psychiatry (2000) 1.08
The visual paired-comparison task as a measure of declarative memory. Proc Natl Acad Sci U S A (2000) 1.07
Alzheimer disease: amyloidogenesis, the presenilins and animal models. Biochim Biophys Acta (2006) 1.07
Arousal and stress effects on consolidation and reconsolidation of recognition memory. Neuropsychopharmacology (2007) 1.07
The ibogaine medical subculture. J Ethnopharmacol (2007) 1.06
Ageing: the cholinergic hypothesis of cognitive decline. Curr Opin Neurobiol (1995) 1.05
Optogenetics in the nonhuman primate. Prog Brain Res (2012) 1.04
Associative learning in zebrafish (Danio rerio) in the plus maze. Behav Brain Res (2009) 1.04
Zebrafish: a model for the study of addiction genetics. Hum Genet (2011) 1.03
Optogenetic probing of functional brain circuitry. Exp Physiol (2010) 1.02
A three-dimensional digital atlas of the zebrafish brain. Neuroimage (2010) 1.02
Effect of cigarette smoking on prepulse inhibition of the acoustic startle reflex in healthy male smokers. Psychopharmacology (Berl) (1996) 1.02
Effects of nicotine and stress on startle amplitude and sensory gating depend on rat strain and sex. Pharmacol Biochem Behav (1999) 1.01
Behavioral screening for neuroactive drugs in zebrafish. Dev Neurobiol (2012) 1.01
Zebrafish: An in vivo model for the study of neurological diseases. Neuropsychiatr Dis Treat (2008) 1.01
Behavioral and physiological effects of acute ketamine exposure in adult zebrafish. Neurotoxicol Teratol (2011) 1.00
Prepulse inhibition of acoustic startle, a measure of sensorimotor gating: effects of antipsychotics and other agents in rats. Pharmacol Biochem Behav (1995) 0.99
Aging of the circadian system in zebrafish and the effects of melatonin on sleep and cognitive performance. Brain Res Bull (2007) 0.99
Associative learning performance is impaired in zebrafish (Danio rerio) by the NMDA-R antagonist MK-801. Neurobiol Learn Mem (2011) 0.98
Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish. Behav Brain Res (2009) 2.56
Measuring behavioral and endocrine responses to novelty stress in adult zebrafish. Nat Protoc (2010) 1.90
Analyzing habituation responses to novelty in zebrafish (Danio rerio). Behav Brain Res (2009) 1.69
Three-dimensional neurophenotyping of adult zebrafish behavior. PLoS One (2011) 1.37
Modeling anxiety using adult zebrafish: a conceptual review. Neuropharmacology (2011) 1.28
Premature aging in vitamin D receptor mutant mice. J Steroid Biochem Mol Biol (2009) 1.22
Characterization of behavioral and endocrine effects of LSD on zebrafish. Behav Brain Res (2010) 1.14
25-Hydroxyvitamin D(3) is an agonistic vitamin D receptor ligand. J Steroid Biochem Mol Biol (2009) 1.12
Modeling withdrawal syndrome in zebrafish. Behav Brain Res (2009) 1.10
Pharmacological modulation of anxiety-like phenotypes in adult zebrafish behavioral models. Prog Neuropsychopharmacol Biol Psychiatry (2010) 1.09
Zebrafish models to study drug abuse-related phenotypes. Rev Neurosci (2011) 1.05
Controlled substances and innovation of biomedicine: a preclinical perspective. Nat Rev Neurosci (2013) 1.05
Automated high-throughput neurophenotyping of zebrafish social behavior. J Neurosci Methods (2012) 1.01
Behavioral and physiological effects of acute ketamine exposure in adult zebrafish. Neurotoxicol Teratol (2011) 1.00
Age of the donor reduces the ability of human adipose-derived stem cells to alleviate symptoms in the experimental autoimmune encephalomyelitis mouse model. Stem Cells Transl Med (2013) 0.96
The effects of chronic social defeat stress on mouse self-grooming behavior and its patterning. Behav Brain Res (2010) 0.95
Unique and potent effects of acute ibogaine on zebrafish: the developing utility of novel aquatic models for hallucinogenic drug research. Behav Brain Res (2012) 0.94
Understanding spatio-temporal strategies of adult zebrafish exploration in the open field test. Brain Res (2012) 0.94
Serum cholesterol and expression of ApoAI, LXRbeta and SREBP2 in vitamin D receptor knock-out mice. J Steroid Biochem Mol Biol (2009) 0.94
Multipotent stromal cells alleviate inflammation, neuropathology, and symptoms associated with globoid cell leukodystrophy in the twitcher mouse. Stem Cells (2013) 0.93
Perspectives of zebrafish models of epilepsy: what, how and where next? Brain Res Bull (2011) 0.93
Modeling seizure-related behavioral and endocrine phenotypes in adult zebrafish. Brain Res (2010) 0.91
High-throughput screening of stem cell therapy for globoid cell leukodystrophy using automated neurophenotyping of twitcher mice. Behav Brain Res (2012) 0.90
Behavioral effects of MDMA ('ecstasy') on adult zebrafish. Behav Pharmacol (2011) 0.89
Behavioral and physiological effects of RDX on adult zebrafish. Comp Biochem Physiol C Toxicol Pharmacol (2011) 0.89
Acute stress disrupts performance of zebrafish in the cued and spatial memory tests: the utility of fish models to study stress-memory interplay. Behav Processes (2011) 0.89
Vestibular dysfunction in vitamin D receptor mutant mice. J Steroid Biochem Mol Biol (2009) 0.88
Behavioral effects of bidirectional modulators of brain monoamines reserpine and d-amphetamine in zebrafish. Brain Res (2013) 0.88
The covariation of acoustic features of infant cries and autonomic state. Physiol Behav (2013) 0.87
Experimental models of anxiety for drug discovery and brain research. Methods Mol Biol (2010) 0.87
Homebase behavior of zebrafish in novelty-based paradigms. Behav Processes (2010) 0.87
Effects of hallucinogenic agents mescaline and phencyclidine on zebrafish behavior and physiology. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.86
BDNF in anxiety and depression. Science (2006) 0.86
Towards high-throughput phenotyping of complex patterned behaviors in rodents: focus on mouse self-grooming and its sequencing. Behav Brain Res (2011) 0.85
Neophobia, sensory and cognitive functions, and hedonic responses in vitamin D receptor mutant mice. J Steroid Biochem Mol Biol (2007) 0.85
Perspectives on zebrafish models of hallucinogenic drugs and related psychotropic compounds. ACS Chem Neurosci (2013) 0.83
Neurosteroid vitamin D system as a nontraditional drug target in neuropsychopharmacology. Behav Pharmacol (2010) 0.83
Anxiolytic drug discovery: what are the novel approaches and how can we improve them? Expert Opin Drug Discov (2013) 0.82
Alterations in grooming activity and syntax in heterozygous SERT and BDNF knockout mice: the utility of behavior-recognition tools to characterize mutant mouse phenotypes. Brain Res Bull (2012) 0.82
Perspectives on experimental models of serotonin syndrome in zebrafish. Neurochem Int (2013) 0.81
The Zebrafish Neurophenome Database (ZND): a dynamic open-access resource for zebrafish neurophenotypic data. Zebrafish (2011) 0.81
Potential translational targets revealed by linking mouse grooming behavioral phenotypes to gene expression using public databases. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.81
Developing 'integrative' zebrafish models of behavioral and metabolic disorders. Behav Brain Res (2013) 0.80
Constructing the habituome for phenotype-driven zebrafish research. Behav Brain Res (2012) 0.80
Effects of piracetam on behavior and memory in adult zebrafish. Brain Res Bull (2011) 0.80
Mouse models for studying depression-like states and antidepressant drugs. Methods Mol Biol (2010) 0.79
Qui non proficit, deficit: experimental models for 'integrative' research of affective disorders. J Affect Disord (2009) 0.78
Brain-derived neurotrophic factor, serotonin transporter, and depression: comment on Kaufman et al. Biol Psychiatry (2006) 0.78
Psychopharmacological effects of acute exposure to kynurenic acid (KYNA) in zebrafish. Pharmacol Biochem Behav (2013) 0.77
Experimental models for anxiolytic drug discovery in the era of omes and omics. Expert Opin Drug Discov (2011) 0.77
Aberrant nest building and prolactin secretion in vitamin D receptor mutant mice. J Steroid Biochem Mol Biol (2007) 0.77
The failure of anxiolytic therapies in early clinical trials: what needs to be done. Expert Opin Investig Drugs (2015) 0.76
Refining psychiatric genetics: from 'mouse psychiatry' to understanding complex human disorders. Behav Pharmacol (2008) 0.76
Acoustic features of prairie vole (Microtus ochrogaster) ultrasonic vocalizations covary with heart rate. Physiol Behav (2014) 0.76
Skin too thin? The developing utility of zebrafish skin (neuro)pharmacology for CNS drug discovery research. Brain Res Bull (2013) 0.76
Novel experimental models and paradigms for neuropsychiatric disorders: Editorial. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.75